Two heart-failure treatments, Novartis AG’s drug Entresto and St. Jude’s CardioMEMS device, have come under scrutiny after a report was published by a research...
The Food and Drug Administration approved a new drug today for clinical use that will cut cardiovascular hospitalizations and deaths by approximately...